BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27166488)

  • 1. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].
    Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
    Gold AB; Herrmann N; Lanctôt KL
    Curr Drug Targets; 2011 Feb; 12(2):243-55. PubMed ID: 20863277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of lithium in neurodegenerative diseases: new registries for old actors].
    Pérez-Martínez DA
    Neurologia; 2009 Apr; 24(3):143-6. PubMed ID: 19418288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
    Chuang DM
    Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?
    Chuang DM; Manji HK
    Biol Psychiatry; 2007 Jul; 62(1):4-6. PubMed ID: 17572175
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.
    Camins A; Verdaguer E; Junyent F; Yeste-Velasco M; Pelegrí C; Vilaplana J; Pallás M
    CNS Neurosci Ther; 2009; 15(4):333-44. PubMed ID: 19889130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Machado-Vieira R; Manji HK; Zarate CA
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective action of lithium in disorders of the central nervous system.
    Chiu CT; Chuang DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3 inhibitors and disease.
    Hernández F; Nido JD; Avila J; Villanueva N
    Mini Rev Med Chem; 2009 Aug; 9(9):1024-9. PubMed ID: 19689399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lithium ascorbate as a cerebroprotective agent in a model of ischemic stroke].
    Plotnikov EV; Litvak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):29-32. PubMed ID: 32307427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium.
    Aghdam SY; Barger SW
    Curr Alzheimer Res; 2007 Feb; 4(1):21-31. PubMed ID: 17316163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroprotective actions of lithium].
    Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.